1887

Abstract

Human coronavirus strain 229E (HCoV-229E) commonly causes upper respiratory tract infections. However, lower respiratory tract infections can occur in some individuals, indicating that cells in the distal lung are susceptible to HCoV-229E. This study determined the virus susceptibility of primary cultures of human alveolar epithelial cells and alveolar macrophages (AMs). Fluorescent antibody staining indicated that HCoV-229E could readily infect AMs, but no evidence was found for infection in differentiated alveolar epithelial type II cells and only a very low level of infection in type II cells transitioning to the type I-like cell phenotype. However, a human bronchial epithelial cell line (16HBE) was readily infected. The innate immune response of AMs to HCoV-229E infection was evaluated for cytokine production and interferon (IFN) gene expression. AMs secreted significant amounts of tumour necrosis factor alpha (TNF-α), regulated on activation normal T-cell expressed and secreted (RANTES/CCL5) and macrophage inflammatory protein 1β (MIP-1β/CCL4) in response to HCoV-229E infection, but these cells exhibited no detectable increase in IFN-β or interleukin-29 in mRNA levels. AMs from smokers had reduced secretion of TNF-α compared with non-smokers in response to HCoV-229E infection. Surfactant protein A (SP-A) and SP-D are part of the innate immune system in the distal lung. Both surfactant proteins bound to HCoV-229E, and pre-treatment of HCoV-229E with SP-A or SP-D inhibited infection of 16HBE cells. In contrast, there was a modest reduction in infection in AMs by SP-A, but not by SP-D. In summary, AMs are an important target for HCoV-229E, and they can mount a pro-inflammatory innate immune response to infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.038414-0
2012-03-01
2020-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/3/494.html?itemId=/content/journal/jgv/10.1099/vir.0.038414-0&mimeType=html&fmt=ahah

References

  1. Banach B. S., Orenstein J. M., Fox L. M., Randell S. H., Rowley A. H., Baker S. C. 2009; Human airway epithelial cell culture to identify new respiratory viruses: coronavirus NL63 as a model. J Virol Methods 156:19–26 [CrossRef][PubMed]
    [Google Scholar]
  2. Beckham J. D., Cadena A., Lin J., Piedra P. A., Glezen W. P., Greenberg S. B., Atmar R. L. 2005; Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 50:322–330 [CrossRef][PubMed]
    [Google Scholar]
  3. Chen H., Cowan M. J., Hasday J. D., Vogel S. N., Medvedev A. E. 2007; Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-κB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol 179:6097–6106[PubMed] [CrossRef]
    [Google Scholar]
  4. Cheung C. Y., Poon L. L., Ng I. H., Luk W., Sia S. F., Wu M. H., Chan K. H., Yuen K. Y., Gordon S. other authors 2005; Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol 79:7819–7826 [CrossRef][PubMed]
    [Google Scholar]
  5. Cozens A. L., Yezzi M. J., Kunzelmann K., Ohrui T., Chin L., Eng K., Finkbeiner W. E., Widdicombe J. H., Gruenert D. C. 1994; CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10:38–47[PubMed] [CrossRef]
    [Google Scholar]
  6. de Lang A., Baas T., Smits S. L., Katze M. G., Osterhaus A. D., Haagmans B. L. 2009; Unraveling the complexities of the interferon response during SARS-CoV infection. Future Virol 4:71–78 [CrossRef][PubMed]
    [Google Scholar]
  7. Desforges M., Miletti T. C., Gagnon M., Talbot P. J. 2007; Activation of human monocytes after infection by human coronavirus 229E. Virus Res 130:228–240 [CrossRef][PubMed]
    [Google Scholar]
  8. Dijkman R., van der Hoek L. 2009; Human coronaviruses 229E and NL63: close yet still so far. J Formos Med Assoc 108:270–279 [CrossRef][PubMed]
    [Google Scholar]
  9. Dominguez S. R., Robinson C. C., Holmes K. V. 2009; Detection of four human coronaviruses in respiratory infections in children: a one-year study in Colorado. J Med Virol 81:1597–1604 [CrossRef][PubMed]
    [Google Scholar]
  10. El-Sahly H. M., Atmar R. L., Glezen W. P., Greenberg S. B. 2000; Spectrum of clinical illness in hospitalized patients with “common cold” virus infections. Clin Infect Dis 31:96–100 [CrossRef][PubMed]
    [Google Scholar]
  11. Fehrenbach H. 2001; Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2:33–46 [CrossRef][PubMed]
    [Google Scholar]
  12. Fouchier R. A., Hartwig N. G., Bestebroer T. M., Niemeyer B., de Jong J. C., Simon J. H., Osterhaus A. D. 2004; A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A 101:6212–6216 [CrossRef][PubMed]
    [Google Scholar]
  13. Funk C. J., Manzer R., Miura T. A., Groshong S. D., Ito Y., Travanty E. A., Leete J., Holmes K. V., Mason R. J. 2009; Rat respiratory coronavirus infection: replication in airway and alveolar epithelial cells and the innate immune response. J Gen Virol 90:2956–2964 [CrossRef][PubMed]
    [Google Scholar]
  14. Gaschler G. J., Zavitz C. C., Bauer C. M., Skrtic M., Lindahl M., Robbins C. S., Chen B., Stämpfli M. R. 2008; Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages. Am J Respir Cell Mol Biol 38:218–226 [CrossRef][PubMed]
    [Google Scholar]
  15. Gaunt E. R., Hardie A., Claas E. C., Simmonds P., Templeton K. E. 2010; Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 48:2940–2947 [CrossRef][PubMed]
    [Google Scholar]
  16. Graat J. M., Schouten E. G., Heijnen M. L., Kok F. J., Pallast E. G., de Greeff S. C., Dorigo-Zetsma J. W. 2003; A prospective, community-based study on virologic assessment among elderly people with and without symptoms of acute respiratory infection. J Clin Epidemiol 56:1218–1223 [CrossRef][PubMed]
    [Google Scholar]
  17. Haagsman H. P., Hogenkamp A., van Eijk M., Veldhuizen E. J. 2008; Surfactant collectins and innate immunity. Neonatology 93:288–294 [CrossRef][PubMed]
    [Google Scholar]
  18. Hartshorn K. L. 2010; Role of surfactant protein A and D (SP-A and SP-D) in human antiviral host defense. Front Biosci (Schol Ed) S2:527–546 [CrossRef][PubMed]
    [Google Scholar]
  19. Hartshorn K. L., White M. R., Voelker D. R., Coburn J., Zaner K., Crouch E. C. 2000; Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem J 351:449–458 [CrossRef][PubMed]
    [Google Scholar]
  20. Job E. R., Deng Y. M., Tate M. D., Bottazzi B., Crouch E. C., Dean M. M., Mantovani A., Brooks A. G., Reading P. C. 2010; Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J Immunol 185:4284–4291 [CrossRef][PubMed]
    [Google Scholar]
  21. Kopecky-Bromberg S. A., Martinez-Sobrido L., Palese P. 2006; 7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase. J Virol 80:785–793 [CrossRef][PubMed]
    [Google Scholar]
  22. Kopecky-Bromberg S. A., Martínez-Sobrido L., Frieman M., Baric R. A., Palese P. 2007; Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81:548–557 [CrossRef][PubMed]
    [Google Scholar]
  23. Kumagai Y., Takeuchi O., Kato H., Kumar H., Matsui K., Morii E., Aozasa K., Kawai T., Akira S. 2007; Alveolar macrophages are the primary interferon-α producer in pulmonary infection with RNA viruses. Immunity 27:240–252 [CrossRef][PubMed]
    [Google Scholar]
  24. Kuypers J., Martin E. T., Heugel J., Wright N., Morrow R., Englund J. A. 2007; Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics 119:e70–e76 [CrossRef][PubMed]
    [Google Scholar]
  25. Leth-Larsen R., Zhong F., Chow V. T., Holmskov U., Lu J. 2007; The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages. Immunobiology 212:201–211 [CrossRef][PubMed]
    [Google Scholar]
  26. McIntosh K., Chao R. K., Krause H. E., Wasil R., Mocega H. E., Mufson M. A. 1974; Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis 130:502–507 [CrossRef][PubMed]
    [Google Scholar]
  27. Minakshi R., Padhan K., Rani M., Khan N., Ahmad F., Jameel S. 2009; The SARS coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor. PLoS One 4:e8342 [CrossRef][PubMed]
    [Google Scholar]
  28. Mossel E. C., Wang J., Jeffers S., Edeen K. E., Wang S., Cosgrove G. P., Funk C. J., Manzer R., Miura T. A. other authors 2008; SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. Virology 372:127–135 [CrossRef][PubMed]
    [Google Scholar]
  29. Narayanan K., Huang C., Lokugamage K., Kamitani W., Ikegami T., Tseng C.-T., Makino S. 2008; Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol 82:4471–4479 [CrossRef][PubMed]
    [Google Scholar]
  30. Page K., Li J., Zhou L., Iasvovskaia S., Corbit K. C., Soh J. W., Weinstein I. B., Brasier A. R., Lin A., Hershenson M. B. 2003; Regulation of airway epithelial cell NF-κB-dependent gene expression by protein kinase C delta. J Immunol 170:5681–5689[PubMed] [CrossRef]
    [Google Scholar]
  31. Pene F., Merlat A., Vabret A., Rozenberg F., Buzyn A., Dreyfus F., Cariou A., Freymuth F., Lebon P. 2003; Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis 37:929–932 [CrossRef][PubMed]
    [Google Scholar]
  32. Perlman S. 1998; Pathogenesis of coronavirus-induced infections. Review of pathological and immunological aspects. Adv Exp Med Biol 440:503–513 [CrossRef][PubMed]
    [Google Scholar]
  33. Pyrc K., Berkhout B., van der Hoek L. 2007; The novel human coronaviruses NL63 and HKU1. J Virol 81:3051–3057 [CrossRef][PubMed]
    [Google Scholar]
  34. Pyrc K., Sims A. C., Dijkman R., Jebbink M., Long C., Deming D., Donaldson E., Vabret A., Baric R. other authors 2010; Culturing the unculturable: human coronavirus HKU1 infects, replicates, and produces progeny virions in human ciliated airway epithelial cell cultures. J Virol 84:11255–11263 [CrossRef][PubMed]
    [Google Scholar]
  35. Reading P. C., Morey L. S., Crouch E. C., Anders E. M. 1997; Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71:8204–8212[PubMed]
    [Google Scholar]
  36. Sakabe S., Iwatsuki-Horimoto K., Takano R., Nidom C. A., Le M. Q., Nagamura-Inoue T., Horimoto T., Yamashita N., Kawaoka Y. 2011; Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. J Gen Virol 92:1428–1434 [CrossRef][PubMed]
    [Google Scholar]
  37. Severance E. G., Bossis I., Dickerson F. B., Stallings C. R., Origoni A. E., Sullens A., Yolken R. H., Viscidi R. P. 2008; Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population. Clin Vaccine Immunol 15:1805–1810 [CrossRef][PubMed]
    [Google Scholar]
  38. van der Hoek L., Pyrc K., Jebbink M. F., Vermeulen-Oost W., Berkhout R. J., Wolthers K. C., Wertheim-van Dillen P. M., Kaandorp J., Spaargaren J., Berkhout B. 2004; Identification of a new human coronavirus. Nat Med 10:368–373 [CrossRef][PubMed]
    [Google Scholar]
  39. Wang G., Deering C., Macke M., Shao J., Burns R., Blau D. M., Holmes K. V., Davidson B. L., Perlman S., McCray P. B. Jr 2000; Human coronavirus 229E infects polarized airway epithelia from the apical surface. J Virol 74:9234–9239 [CrossRef][PubMed]
    [Google Scholar]
  40. Wang J., Edeen K., Manzer R., Chang Y., Wang S., Chen X., Funk C. J., Cosgrove G. P., Fang X., Mason R. J. 2007; Differentiated human alveolar epithelial cells and reversibility of their phenotype in vitro . Am J Respir Cell Mol Biol 36:661–668 [CrossRef][PubMed]
    [Google Scholar]
  41. Wang J., Oberley-Deegan R., Wang S., Nikrad M., Funk C. J., Hartshorn K. L., Mason R. J. 2009; Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-λ1) in response to influenza A infection. J Immunol 182:1296–1304[PubMed] [CrossRef]
    [Google Scholar]
  42. Wang J., Nikrad M. P., Phang T., Gao B., Alford T., Ito Y., Edeen K., Travanty E. A., Kosmider B. other authors 2011; Innate immune response to influenza A virus in differentiated human alveolar type II cells. Am J Respir Cell Mol Biol 45:582–591 [CrossRef][PubMed]
    [Google Scholar]
  43. Wentworth D. E., Holmes K. V. 2001; Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation. J Virol 75:9741–9752 [CrossRef][PubMed]
    [Google Scholar]
  44. Woo P. C., Lau S. K., Chu C.-M., Chan K.-H., Tsoi H.-W., Huang Y., Wong B. H., Poon R. W., Cai J. J. other authors 2005; Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79:884–895 [CrossRef][PubMed]
    [Google Scholar]
  45. Wurfel M. M., Park W. Y., Radella F., Ruzinski J., Sandstrom A., Strout J., Bumgarner R. E., Martin T. R. 2005; Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity. J Immunol 175:2570–2578[PubMed] [CrossRef]
    [Google Scholar]
  46. Yeager C. L., Ashmun R. A., Williams R. K., Cardellichio C. B., Shapiro L. H., Look A. T., Holmes K. V. 1992; Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420–422 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.038414-0
Loading
/content/journal/jgv/10.1099/vir.0.038414-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error